Table 5.

Movement Disorder Scales

	RCT				OLE
Mean (SD)	n	Ziprasidone	n	Placebo	n	Ziprasidone
SARS total score
Baseline	189	0.7 (2.1)	87	0.6 (1.7)	221	0.9 (2.2)
Change from baseline to week 6− or week 26−LOCF	189	0.3 (2.5)	86	−0.1 (0.6)	206	−0.2 (1.5)
BARS
Baseline	190	0.1 (0.5)	88	0.1 (0.3)	221	0.1 (0.4)
Change from baseline to week 6− or week 26−LOCF	190	0.0 (0.6)	87	0.0 (0.2)	206	0.1 (0.5)
AIMS
Baseline	190	0.2 (0.8)	88	0.3 (0.9)	221	0.3 (1.2)
Change from baseline to week 6− or week 26−LOCF	190	0.0 (0.8)	87	0.0 (0.7)	206	0.0 (1.0)

RCT, randomized controlled trial; OLE, open-label extension; LOCF, last observation carried forward; BARS, Barnes Akathisia Rating Scale; AIMS, Abnormal Involuntary Movement Scale; SARS, Simpson-Angus Rating Scale.